Truvestments Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $313K | Sell |
2,247
-31
| -1% | -$4.34K | 0.06% | 257 |
|
|
2025
Q4 | $280K | Buy |
2,278
+261
| +13% | +$31.7K | 0.05% | 253 |
|
|
2025
Q3 | $224K | Sell |
2,017
-532
| -21% | -$60.5K | 0.04% | 277 |
|
|
2025
Q2 | $283K | Sell |
2,549
-64
| -2% | -$6.81K | 0.06% | 221 |
|
|
2025
Q1 | $293K | Buy |
2,613
+1,010
| +63% | +$104K | 0.06% | 207 |
|
|
2024
Q4 | $148K | Buy |
1,603
+104
| +7% | +$9.36K | 0.04% | 247 |
|
|
2024
Q3 | $126K | Buy |
+1,499
| New | +$114K | 0.03% | 258 |
|
|
2024
Q2 | – | Sell |
-1,476
| Closed | -$108K | – | 407 |
|
|
2024
Q1 | $108K | Buy |
1,476
+85
| +6% | +$6.54K | 0.04% | 291 |
|
|
2023
Q4 | $113K | Buy |
1,391
+775
| +126% | +$60.3K | 0.05% | 248 |
|
|
2023
Q3 | $46.2K | Sell |
616
-14
| -2% | -$1.08K | 0.02% | 296 |
|
|
2023
Q2 | $48.5K | Buy |
630
+175
| +38% | +$14K | 0.02% | 296 |
|
|
2023
Q1 | $37.8K | Sell |
455
-237
| -34% | -$19.6K | 0.02% | 318 |
|
|
2022
Q4 | $59.4K | Buy |
692
+37
| +6% | +$2.93K | 0.03% | 287 |
|
|
2022
Q3 | $40K | Sell |
655
-199
| -23% | -$12.5K | 0.03% | 271 |
|
|
2022
Q2 | $53K | Buy |
+854
| New | +$52.9K | 0.03% | 251 |
|
|
2022
Q1 | – | Sell |
-849
| Closed | -$62K | – | 317 |
|
|
2021
Q4 | $62K | Buy |
849
+457
| +117% | +$31.5K | 0.03% | 244 |
|
|
2021
Q3 | $27K | Buy |
392
+2
| +0.5% | +$141 | 0.01% | 298 |
|
|
2021
Q2 | $27K | Sell |
390
-1,894
| -83% | -$126K | 0.01% | 300 |
|
|
2021
Q1 | $148K | Buy |
2,284
+2
| +0.1% | +$129 | 0.08% | 181 |
|
|
2020
Q4 | $132K | Buy |
2,282
+564
| +33% | +$34K | 0.09% | 176 |
|
|
2020
Q3 | $109K | Buy |
1,718
+33
| +2% | +$2.29K | 0.1% | 145 |
|
|
2020
Q2 | $129K | Sell |
1,685
-346
| -17% | -$26.5K | 0.13% | 124 |
|
|
2020
Q1 | $151K | Buy |
+2,031
| New | +$140K | 0.19% | 102 |
|
|
2019
Q4 | – | Sell |
-1,627
| Closed | -$103K | – | 312 |
|
|
2019
Q3 | $103K | Buy |
1,627
+2
| +0.1% | +$131 | 0.07% | 175 |
|
|
2019
Q2 | $110K | Sell |
1,625
-128
| -7% | -$8.42K | 0.07% | 174 |
|
|
2019
Q1 | $114K | Buy |
+1,753
| New | +$117K | 0.09% | 147 |
|
|
2018
Q3 | $210K | Buy |
+2,726
| New | +$206K | 0.1% | 173 |
|
Other funds holding GILD
VCM
VPM
Truvestments Capital's GILD Position: Q1 2026 in Review
Truvestments Capital reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, selling an estimated $4.34K and leaving 2,247 shares worth $313K. The position accounts for 0.06% of the portfolio, ranked #257.
Truvestments Capital first reported a position in GILD in Q3 2018 and has held it in 27 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Truvestments Capital held 2,247 shares of Gilead Sciences worth $313K as of Q1 2026.
- Truvestments Capital sold 31 Gilead Sciences shares in Q1 2026, an estimated $4.34K.
- Gilead Sciences made up 0.06% of Truvestments Capital's portfolio in Q1 2026, its #257 holding.
- Truvestments Capital first reported a position in Gilead Sciences in Q3 2018 and has held it in 27 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.